XERAVA® en
Stelopharm GmbH
your reliable partner for the distribution
of pharmaceutical products
Stelopharm GmbH
your reliable partner for the distribution
of pharmaceutical products
The following content is intended for
medical professionals only.
Xerava® 100 mg
100 mg Powder for a concentrate for the preparation of an infusion solution. Light yellow to dark yellow clumps.
Manufactured in Europe
Qualitative and quantitative composition1
- The active ingredient is eravacycline
- Each ampoule contains 100 mg eravacycline
- After reconstitution, 1 ml solution contains 20 mg Eravacyclin
- After further dilution 1 ml solution contains 0.6 mg Eravacyclin
- For a complete list of other ingredients, see section 6.1. of the Product Information 06/2024
- Xerava is an antibiotic of the tetracycline class
Indications
Xerava is indicated for the treatment of complicated intra-abdominal infections (cIAI) in adults (see
sections 4.4 and 5.1 of the Product Information, 06/2024.
The official guidelines for the appropriate use of antibacterial agents must be observed.
1Xerava® Summary of Product Characteristics, as of 06/2024
You can find the product information on the website of the European Medicines Agency here.